New hope for brain tumor patients: targeted radiation shows promise
NCT ID NCT03971461
First seen Mar 27, 2026 · Last updated Apr 29, 2026 · Updated 3 times
Summary
This study tests a drug called Lutathera, which delivers radiation directly to meningioma tumor cells. It is for adults with growing or high-risk meningiomas that have not responded to standard treatments. The goal is to see if the drug can stop or slow tumor growth for at least 6 months. Participants receive four doses over 8 weeks and are monitored with scans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.